Who
Richard Giltner
Director
Company insider
Files Form 4 as: Director, United Therapeutics.
In numbers
- Trades disclosed
- 126
- Buys
- 0
- Sells
- 21
- Bought
- $0
- Sold
- $17.4M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 29 Apr 2009
- Last trade
- 22 Jul 2026
- Last filed
- 23 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —760 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —760 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,310 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,310 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,310 at $0.00 | filing |
| 9 Jul 2026filed 13 Jul 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,310 at $0.00 | filing |
| 25 Jul 2025filed 28 Jul 2025 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,190 at $0.00 | filing |
| 25 Jul 2025filed 28 Jul 2025 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,190 at $0.00 | filing |
| 24 Jul 2025filed 28 Jul 2025 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,310 at $0.00 | filing |
| 24 Jun 2025filed 25 Jun 2025 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 24 Jun 2025filed 25 Jun 2025 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | $877K5,000 at $175.43 | filing |
| 24 Jun 2025filed 25 Jun 2025 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $879K3,036 at $289.60 | filing |
| 5 Nov 2024filed 6 Nov 2024 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
| 5 Nov 2024filed 6 Nov 2024 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | $1.8M10,000 at $175.43 | filing |
| 5 Nov 2024filed 6 Nov 2024 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $3.3M8,571 at $381.61 | filing |
| 5 Nov 2024filed 6 Nov 2024 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $546K1,429 at $382.28 | filing |
| 25 Jul 2024filed 26 Jul 2024 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,190 at $0.00 | filing |
| 13 Jul 2024filed 15 Jul 2024 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,800 at $0.00 | filing |
| 13 Jul 2024filed 15 Jul 2024 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | —1,800 at $0.00 | filing |
| 6 Mar 2024filed 7 Mar 2024 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,000 at $0.00 | filing |
News
Share Repurchase Plan Announced by United Therapeutics (NASDAQ:UTHR) Board of DirectorsUTHR · tickerreport.com · 23 Oct 2026United Therapeutics (NASDAQ:UTHR) Price Target Raised to $725.00UTHR · dailypolitical.com · 22 Oct 2026Contrasting Xenon Pharmaceuticals (NASDAQ:XENE) and United Therapeutics (NASDAQ:UTHR)UTHR · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Richard Giltner; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.